| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,270 |
9,294 |
$341K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,198 |
2,011 |
$236K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,002 |
1,840 |
$91K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,865 |
1,638 |
$78K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
322 |
305 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
358 |
319 |
$15K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
237 |
212 |
$12K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
314 |
282 |
$11K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
242 |
226 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
214 |
193 |
$8K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
621 |
305 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
224 |
165 |
$6K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
475 |
453 |
$5K |
| 90686 |
|
512 |
490 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
575 |
529 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
218 |
181 |
$3K |
| 90670 |
|
244 |
225 |
$2K |
| 99490 |
Ccm add 20min |
354 |
325 |
$2K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
785 |
682 |
$2K |
| 90647 |
|
207 |
193 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
919 |
801 |
$2K |
| 81003 |
|
678 |
590 |
$1K |
| 90633 |
|
158 |
146 |
$1K |
| 84443 |
Thyroid stimulating hormone (TSH) |
80 |
74 |
$992.28 |
| 90723 |
|
110 |
100 |
$936.88 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
34 |
33 |
$920.75 |
| 84480 |
|
81 |
75 |
$887.18 |
| 90734 |
|
104 |
97 |
$860.40 |
| 80061 |
Lipid panel |
119 |
109 |
$824.97 |
| T1502 |
Administration of oral, intramuscular and/or subcutaneous medication by health care agency/professional, per visit |
608 |
537 |
$795.20 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
460 |
395 |
$768.32 |
| 80053 |
Comprehensive metabolic panel |
72 |
68 |
$606.02 |
| 84439 |
|
81 |
75 |
$564.92 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
59 |
53 |
$564.05 |
| 90649 |
|
55 |
51 |
$439.76 |
| 90685 |
|
47 |
40 |
$325.04 |
| 90700 |
|
31 |
31 |
$267.68 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$233.70 |
| 90710 |
|
25 |
25 |
$210.32 |
| 82962 |
|
121 |
106 |
$201.88 |
| G0008 |
Administration of influenza virus vaccine |
40 |
37 |
$185.40 |
| 90715 |
|
16 |
14 |
$133.84 |
| 90713 |
|
12 |
12 |
$114.72 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
15 |
13 |
$112.00 |
| 3078F |
|
86 |
74 |
$0.00 |
| 3074F |
|
87 |
77 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
14 |
14 |
$0.00 |